Drug interactions
Indacaterol-glycopyrronium + Pyridostigmine
Severity: Minor
Indacaterol-glycopyrronium and Pyridostigmine: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Pyridostigmine increases cholinergic activity while glycopyrronium blocks muscarinic receptors, so their effects partly oppose each other. Systemic exposure to inhaled glycopyrronium is low, limiting the impact, though muscarinic blockade can mask pyridostigmine side effects.
What this interaction means in plain words
Indacaterol-glycopyrronium and Pyridostigmine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Indacaterol-glycopyrronium belongs to Respiratory; Pyridostigmine belongs to Central Nervous System.
Why it happens
Pharmacodynamic antagonism between a cholinesterase inhibitor and a muscarinic antagonist.
What to do
Monitor myasthenia symptoms and cholinergic adverse effects such as secretions and bradycardia. Adjust pyridostigmine only if control changes.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol-glycopyrronium and Pyridostigmine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Indacaterol-glycopyrronium
Other interactions of Pyridostigmine
Frequently asked questions
Can I take Indacaterol-glycopyrronium with Pyridostigmine?
MediHelp rates the interaction as minor. Indacaterol-glycopyrronium and Pyridostigmine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Pyridostigmine increases cholinergic activity while glycopyrronium blocks muscarinic receptors, so their effects partly oppose each other. Systemic exposure to inhaled glycopyrronium is low, limiting the impact, though muscarinic blockade can mask pyridostigmine side effects.
How serious is the interaction between Indacaterol-glycopyrronium and Pyridostigmine?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor myasthenia symptoms and cholinergic adverse effects such as secretions and bradycardia. Adjust pyridostigmine only if control changes.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
